Page 20 - Read Online
P. 20

Page 4 of 9                                                      Hong et al. J Transl Genet Genom 2018;2:8. I  https://doi.org/10.20517/jtgg.2018.06

               Table 1. Hematological parameters, CRP and PCT
                                                 WCC                             Platelets   CRP    PCT
                Date           Hct (%)  Hb (g/L)  9     PMN (%)  Ly (%)  Mo (%)     9
                                                (10 /L)                          (10 /L)  (mg/L)  (ng/mL)
                2016/3/4         32.6    108     46.37    50.6    39.9    8.9     329      14       0.29
                2016/3/6         26.2    85      26.8     47.5    38.5    12.4    282      21
                2016/3/9         30.60   101     28.3     47.5    41.8    8.7     351      < 8
                2016/3/12        25.7    85      32.28    56.7    35      7.2     396      21
                2016/3/13        28.8    96      29.22    59.2    36.4    4.2     394      9
                2016/3/15        29.6    97      24.51    62.6    30.9    5.1     445      < 8
                2016/3/18        32.2    106     29.48    59.3    32.5    7.2     457      29
                2016/3/21        28      90      15.15    41.2    49.8    7.2     429      < 8
                2016/3/22        25.1    84      16.5     47.9    43.8    7.0     427      < 8
                2016/4/1         25.1    82      22.59    54      35.1    10      361      13       0.13
                2016/4/3         25.6    84      19.72    49.5    41.7    7.3     341      < 8
                2016/4/6         29.2    98      27.43    56.2    34.1    8.9     301      10
                2016/4/10        29.9    97      35.1     61.2    30      7.9     342      10
                2016/4/12        28.5    90      22.75    53.7    37      8.8     341      9
                2016/4/15        25.1    83      34.6     59.5    32.4    7.7     356      61
                2016/4/18        26.9    89      17.15    39.5    48.7    9       382      28
                2016/4/20        26.2    86      13.87    27.7    60.9    9.3     306      < 8
                2016/5/19        28.1    91      37.8     62.4    26.5    9.1     354      75       0.18
                2016/5/23        30.1    101     60.35    68.2    22.2    8       403      70
                2016/5/26        27      88      41.93    66.6    23.2    6.6     371      53
                2016/5/31        27.6    93      49.65    71.5    22      5.5     406      55
                2016/6/3         27      91      57.71    78.6    14.1    7.2     430      110      0.17
                2016/6/6         27.1    90      26.57    58.5    33.5    6.7     417      60
                2016/6/9         22.1    75      30.85    73.2    21.8    3.6     436      42
                2016/6/11        30.5    102     34.61    63.8    29.8    4.3     422      50

               CRP: C reactive protein; PCT: procalcitonin; Hct: haematocrit; Hb: haemoglobin; Ly: lymphocytes; Mo: monocytes; PMN:
               polymorphonuclear neutrophils; WCC: white cell count


               after; his body temperature fluctuated from 37.5 to 38.5 °C and it returned to normal after 3 weeks, then the
               patient was discharged with liver span of 3 cm, spleen palpable 2 cm below the left costal margin.


               Since a thorough history, physical examination, and laboratory workup failed to identify a clear etiology of
               this extremely abnormal case of leukocytosis, genetic analysis was initiated to find the cause. We performed
               TES of the immune disease panel (designed by MyGenostics, Beijing, China) on the pedigree. A total of
               232 genes associated with defects in neutrophil chemotaxis and phagocytosis were selected using a gene
               capture strategy with a GenCap custom exome enrichment kit (MyGenostics, Beijing, China). In ITGB2
               gene, a previously described mutation c.817G>A (p.G273R) was found in a homozygous state [Figure 1A].
               This mutation co-segregated with the phenotype in the family. And a pedigree study showed that his father
               was a carrier of c.817G>A (p.G273R) mutation [Figure 1B], while his mother showed no variant [Figure 1C].
               Furthermore the same allele was configured by qPCR to eliminate the possibility that his mother had a large
               fragment deletion involving this position [Figure 1D].


               DISCUSSION
               LAD-I is a rare immunodeficiency. HSCT remains the only curative option for these children in that
               conventional therapy with antibiotics and immunoglobulin transfusions only improving the symptoms,
               but not correcting the disease. The possibility of LAD-I should be raised with the existence of some typical
               clinical presentations, including delayed cord separation, recurrent severe infections from birth onward, e.g.,
               repeated soft tissue infections, chronic ulcers of the skin and mucous membranes and strong leukocytosis,
                                                                                         [4]
               especially neutrophilia, during periods of infection. Even though flow cytometer (FCM)  provides a tool for
               its diagnosis, it is not available in many hospitals. Genetic analysis is an effective alternative for diagnosis
   15   16   17   18   19   20   21   22   23   24   25